Literature DB >> 10846716

[Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy].

K G Rottach1, J Weiss-Brummer, U Wieland, M Schmauss.   

Abstract

A 28-year-old patient with a 5-year history of bipolar disorder developed signs of encephalopathy 2 weeks after the addition of valproic acid to his treatment regimen of doxepine, risperidone, and biperidene. The clinical signs were drowsiness, ataxic gait, asterixis, and a generalized epileptic seizure. Discontinuation of valproic acid gradually resulted in complete remission of these symptoms. Valproate encephalopathy has been described mainly in patients receiving anticonvulsant polytherapy. This complication might become more prevalent in psychiatric pharmacotherapy due to the increasing use of valproic acid.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10846716     DOI: 10.1007/s001150050575

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  4 in total

Review 1.  Drug-induced cerebellar ataxia: a systematic review.

Authors:  J van Gaalen; F G Kerstens; R P P W M Maas; L Härmark; B P C van de Warrenburg
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

2.  Ultrastructure of astrocytes in the cortex of the hippocampal gyrus and in the neocortex of the temporal lobe in experimental valproate encephalopathy and after valproate withdrawal.

Authors:  Maria E Sobaniec-Lotowska
Journal:  Int J Exp Pathol       Date:  2003-06       Impact factor: 1.925

Review 3.  CNS adverse events associated with antiepileptic drugs.

Authors:  Gina M Kennedy; Samden D Lhatoo
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

4.  Asterixis: a study of 103 patients.

Authors:  Gian Pal; Mark M Lin; Robert Laureno
Journal:  Metab Brain Dis       Date:  2014-03-07       Impact factor: 3.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.